Tyr715
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr715  -  RAPGEF1 (human)

Site Information
DRKDLVLyCEAFLTT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 464132

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 )
Disease tissue studied:
gastric cancer ( 1 ) , multiple myeloma ( 2 )
Relevant cell line - cell type - tissue:
SNU-1 (gastric) ( 1 ) , XG2 (B lymphocyte) ( 2 )

References 

1

Guo A (2006) CST Curation Set: 1642; Year: 2006; Biosample/Treatment: cell line, SNU-1/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

2

Gu T (2006) CST Curation Set: 1239; Year: 2006; Biosample/Treatment: cell line, XG2/IL6 starvation &'||' serum starved; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info